DNA screening could reduce colon cancer deaths in Canada if widely adopted. High participation is key to maximizing health ...

Accurate genomic profiling is essential for clinical decision-making and optimizing treatment recommendations.

Most notably, it will be the first showcase of a simulated longitudinal study comparing a multi-analyte blood-based test (HelioLiver) against ultrasound for the detection of hepatocellular carcinoma ...

Central Institutional Review Board approved, final preparatory steps underway at first transplant centersThree of the top 10 U.S. transplant centers expected to participate in trialNearly 10% of annua ...

China: In a significant advancement for prenatal care, researchers have developed a blood-based classifier called PTerm that ...

Oncocyte has completed its clinical trial design and has received approval from a large central institutional review board (IRB), which is a committee that reviews and oversees the safety and ethics ...

DNA-based NIPT: safe, accurate, and cost-effective screening for fetal chromosomal disorders, now part of public health ...

The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...

Transplantation Direct publication uses assay to identify rejection in patients up to 13 years post-transplantRobust data set of 131 patients with 151 kidney biopsies enrolled over four years at ...

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer ...

Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...